Letko, Brosseau & Associates’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-5,699
Closed -$255K 116
2018
Q3
$255K Hold
5,699
﹤0.01% 99
2018
Q2
$228K Hold
5,699
﹤0.01% 99
2018
Q1
$228K Hold
5,699
﹤0.01% 100
2017
Q4
$245K Sell
5,699
-3,140
-36% -$145K ﹤0.01% 101
2017
Q3
$440K Sell
8,839
-370
-4% -$17.9K ﹤0.01% 89
2017
Q2
$441K Sell
9,209
-800
-8% -$38.2K ﹤0.01% 89
2017
Q1
$453K Sell
10,009
-2,500
-20% -$106K ﹤0.01% 88
2016
Q4
$506K Hold
12,509
﹤0.01% 89
2016
Q3
$478K Sell
12,509
-300
-2% -$12K ﹤0.01% 89
2016
Q2
$536K Hold
12,809
0.01% 90
2016
Q1
$514K Hold
12,809
0.01% 95
2015
Q4
$546K Sell
12,809
-200
-2% -$9.2K 0.01% 90
2015
Q3
$618K Sell
13,009
-646
-5% -$32.9K 0.01% 87
2015
Q2
$676K Sell
13,655
-200
-1% -$10.1K 0.01% 88
2015
Q1
$685K Buy
+13,855
New +$662K 0.01% 88
2013
Q4
Sell
-5,675
Closed -$287K 107
2013
Q3
$287K Sell
5,675
-1,400
-20% -$71.2K ﹤0.01% 95
2013
Q2
$364K Buy
+7,075
New +$377K ﹤0.01% 94

Other funds holding SNY

Letko, Brosseau & Associates's SNY Position: Q4 2018 in Review

Letko, Brosseau & Associates sold out of Sanofi (SNY) in Q4 2018, closing a stake of 5,699 shares — an estimated $255K sold.

Letko, Brosseau & Associates first reported a position in SNY in Q2 2013 and held it in 17 quarters. The position peaked at $685K in Q1 2015. 501 funds tracked by Wall St. Rank hold SNY as of Q4 2018.

  • Letko, Brosseau & Associates reported no remaining Sanofi position as of Q4 2018 after selling out during the quarter.
  • Letko, Brosseau & Associates sold 5,699 Sanofi shares in Q4 2018, an estimated $255K.
  • Letko, Brosseau & Associates first reported a position in Sanofi in Q2 2013 and held it in 17 quarters.
  • Letko, Brosseau & Associates's Sanofi position peaked at $685K in Q1 2015.
  • 501 funds tracked by Wall St. Rank held Sanofi as of Q4 2018.

Based on Letko, Brosseau & Associates's 13F filing for Q4 2018, filed 8 Feb 2019.